Article
Recommendations for (Pharmaco)Genetic Sampling in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation.
Clinical and translational science - 1 Aug 2025
Bokma Anniek, Matic Maja, Ralf Arwin, van den Bosch Bianca J C, Kayser Manfred, van Schaik Ron H N, Lafeber Melvin, Coenen Marieke J H, Atrafi Florence
Abstract excerpt
In patients receiving allogenic hematopoietic stem cell transplantation (aHSCT) complete chimerism is desired. However, this brings a challenge when non-invasive assessment of recipient germline DNA is required for genetic testing. Here, we aim to create awareness for (pharmaco)genetic sampling in patients following aHSCT based on a case report of a patient following aHSCT in which pharmacogenetic analysis was...
Topics
Join the communities discussing this publication.
